248 related articles for article (PubMed ID: 8878051)
21. Pharmacological characterisation of [35S]-GTPgammaS binding to Chinese hamster ovary cell membranes stably expressing cloned human 5-HT1D receptor subtypes.
Thomas DR; Faruq SA; Balcarek JM; Brown AM
J Recept Signal Transduct Res; 1995; 15(1-4):199-211. PubMed ID: 8903941
[TBL] [Abstract][Full Text] [Related]
22. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques.
Nilsson T; Longmore J; Shaw D; Pantev E; Bard JA; Branchek T; Edvinsson L
Eur J Pharmacol; 1999 May; 372(1):49-56. PubMed ID: 10374714
[TBL] [Abstract][Full Text] [Related]
23. Stimulation of cloned human serotonin 5-HT1D beta receptor sites in stably transfected C6 glial cells promotes cell growth.
Pauwels PJ; Wurch T; Amoureux MC; Palmier C; Colpaert FC
J Neurochem; 1996 Jan; 66(1):65-73. PubMed ID: 8522991
[TBL] [Abstract][Full Text] [Related]
24. Agonistic properties of alniditan, sumatriptan and dihydroergotamine on human 5-HT1B and 5-HT1D receptors expressed in various mammalian cell lines.
Lesage AS; Wouters R; Van Gompel P; Heylen L; Vanhoenacker P; Haegeman G; Luyten WH; Leysen JE
Br J Pharmacol; 1998 Apr; 123(8):1655-65. PubMed ID: 9605573
[TBL] [Abstract][Full Text] [Related]
25. 5-Hydroxytryptamine 5-HT1D receptors mediating inhibition of cyclic AMP accumulation in Madin-Darby canine kidney (MDCK) cells.
Schoeffter P; Bobirnac I
Naunyn Schmiedebergs Arch Pharmacol; 1995 Sep; 352(3):256-62. PubMed ID: 8584040
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of cAMP accumulation via recombinant human serotonin 5-HT1A receptors: considerations on receptor effector coupling across systems.
Schoeffter P; Bobirnac I; Boddeke E; Hoyer D
Neuropharmacology; 1997; 36(4-5):429-37. PubMed ID: 9225266
[TBL] [Abstract][Full Text] [Related]
27. Ketanserin and ritanserin discriminate between recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes.
Zgombick JM; Schechter LE; Kucharewicz SA; Weinshank RL; Branchek TA
Eur J Pharmacol; 1995 Sep; 291(1):9-15. PubMed ID: 8549648
[TBL] [Abstract][Full Text] [Related]
28. Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.
Newman-Tancredi A; Conte C; Chaput C; Verrièle L; Audinot-Bouchez V; Lochon S; Lavielle G; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):682-8. PubMed ID: 9205951
[TBL] [Abstract][Full Text] [Related]
29. Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan).
Martin GR; Robertson AD; MacLennan SJ; Prentice DJ; Barrett VJ; Buckingham J; Honey AC; Giles H; Moncada S
Br J Pharmacol; 1997 May; 121(2):157-64. PubMed ID: 9154322
[TBL] [Abstract][Full Text] [Related]
30. Heterologous desensitization is evoked by both agonist and antagonist stimulation of the human 5-HT(7) serotonin receptor.
Krobert KA; Andressen KW; Levy FO
Eur J Pharmacol; 2006 Feb; 532(1-2):1-10. PubMed ID: 16487959
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological analysis of G-protein activation mediated by guinea-pig recombinant 5-HT1B receptors in C6-glial cells: similarities with the human 5-HT1B receptor.
Pauwels PJ; Wurch T; Palmier C; Colpaert FC
Br J Pharmacol; 1998 Jan; 123(1):51-62. PubMed ID: 9484854
[TBL] [Abstract][Full Text] [Related]
32. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
Ellwood AJ; Curtis MJ
Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
[TBL] [Abstract][Full Text] [Related]
33. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
Dumuis A; Sebben M; Bockaert J
Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of noradrenaline release via presynaptic 5-HT1D alpha receptors in human atrium.
Molderings GJ; Frölich D; Likungu J; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):272-80. PubMed ID: 8692281
[TBL] [Abstract][Full Text] [Related]
35. Recombinant saphenous vein 5-HT1B receptors of the rabbit: comparative pharmacology with human 5-HT1B receptors.
Wurch T; Palmier C; Colpaert FC; Pauwels PJ
Br J Pharmacol; 1997 Jan; 120(1):153-9. PubMed ID: 9117091
[TBL] [Abstract][Full Text] [Related]
36. Stereoselectivity of 8-OH-DPAT enantiomers at cloned human 5-HT1D receptor sites.
Pauwels PJ; Colpaert FC
Eur J Pharmacol; 1996 Apr; 300(1-2):137-9. PubMed ID: 8741179
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological characterization of a serotonin receptor (5-HT7) stimulating cAMP production in human corneal epithelial cells.
Crider JY; Williams GW; Drace CD; Katoli P; Senchyna M; Sharif NA
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4837-44. PubMed ID: 14578406
[TBL] [Abstract][Full Text] [Related]
38. 5-Hydroxytryptamine 5-HT1B and 5-HT1D receptors mediating inhibition of adenylate cyclase activity. Pharmacological comparison with special reference to the effects of yohimbine, rauwolscine and some beta-adrenoceptor antagonists.
Schoeffter P; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):285-92. PubMed ID: 2572975
[TBL] [Abstract][Full Text] [Related]
39. Human 5-HT1B receptor stimulated inositol phospholipid hydrolysis in CHO cells: synergy with Gq-coupled receptors.
Dickenson JM; Hill SJ
Eur J Pharmacol; 1998 May; 348(2-3):279-85. PubMed ID: 9652344
[TBL] [Abstract][Full Text] [Related]
40. Functional effects of the 5-HT1D receptor antagonist GR 127,935 at human 5-HT1D alpha, 5-HT1D beta, 5-HT1A and opossum 5-HT1B receptors.
Pauwels PJ; Palmier C
Eur J Pharmacol; 1995 Jul; 290(2):95-103. PubMed ID: 8575538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
